Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105)

Affiliations

• ¹ Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
• ² Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan.
• ³ JCOG Data Center, National Cancer Center Hospital, Tokyo, Japan.
• ⁴ Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan.
• ⁵ Department of Hematology, National Cancer Center Hospital East, Kashiwa, Japan.
• ⁶ Department of Hematology and Oncology, Mie University School of Medicine, Tsu, Japan.
• ⁷ Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan.
• ⁸ Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
• ⁹ Department of Hematology, Gunma University Hospital, Maebashi, Japan.
• ¹⁰ Division of Hematology-Oncology, Chiba Cancer Center, Chiba, Japan.
• ¹¹ Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
• ¹² Department of Hematology and Oncology, University of Fukui, Fukui, Japan.
• ¹³ Department of Hematology, Shiga General Hospital, Moriyama, Japan.
• ¹⁴ Department of Hematology, Hyogo Cancer Center, Akashi, Japan.
• ¹⁵ Division of Medical Oncology, Hematology and Infectious Diseases, Fukuoka University Hospital, Fukuoka, Japan.
• ¹⁶ Department of Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
• ¹⁷ Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
• ¹⁸ Department of Hematology, Oita Prefectural Hospital, Oita, Japan.
• ¹⁹ Division of Hematology, Aichi Medical University, Nagakute, Japan.
• ²⁰ Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
• ²¹ Department of Hematology, National Hospital Organization Nagasaki Medical Center, Ohmura, Japan.
• ²² Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
• ²³ Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
• ²⁴ Department of Clinical Oncology and Hematology, The Jikei University Hospital, Tokyo, Japan.
• ²⁵ Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
• ²⁶ Department of Hematology, International Medical Centre, Saitama Medical University, Saitama, Japan.